Center for Drug Evaluation and Research (U.S.). (2008). Guidance for industry and review staff: Nonclinical safety evaluation of reformulated drug products and products intended for administration by an alternate route. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Drug Evaluation and Research (U.S.). Guidance for Industry and Review Staff: Nonclinical Safety Evaluation of Reformulated Drug Products and Products Intended for Administration by an Alternate Route. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2008.
MLA (9th ed.) CitationCenter for Drug Evaluation and Research (U.S.). Guidance for Industry and Review Staff: Nonclinical Safety Evaluation of Reformulated Drug Products and Products Intended for Administration by an Alternate Route. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 2008.